No services found
No Products found
100ug
ProteoGenix
Recombinant Proteins
Escherichia coli (E. coli)
Elisa, WB
CD81 is a cell surface protein that belongs to the tetraspanin family. It is found in various cell types, including immune cells, endothelial cells, and epithelial cells. CD81 plays a crucial role in cell signaling, cell adhesion, and membrane fusion. In recent years, CD81 has emerged as a potential drug target due to its involvement in various diseases, making it a promising candidate for therapeutic interventions. In this article, we will discuss the structure, activity, and potential applications of CD81 recombinant protein.
CD81 is a transmembrane protein that consists of two extracellular loops, a short cytoplasmic tail, and four transmembrane domains. The extracellular loops are responsible for the interaction with other proteins, while the transmembrane domains facilitate the anchoring of CD81 to the cell membrane. The extracellular loops also contain four conserved cysteine residues that form disulfide bonds, contributing to the stability of the protein structure.
CD81 is involved in various cellular processes, including cell adhesion, migration, proliferation, and signaling. It is a key player in the formation of tetraspanin-enriched microdomains (TEMs) on the cell membrane, which are essential for the organization and function of membrane proteins. CD81 also interacts with other tetraspanins, such as CD9, CD63, and CD82, to form TEMs, which regulate the activity of signaling molecules and modulate various cellular processes.
CD81 is also known to interact with several proteins, including integrins, major histocompatibility complex (MHC) class II molecules, and viral envelope glycoproteins. These interactions are crucial for the entry of viruses, such as hepatitis C virus (HCV) and human immunodeficiency virus (HIV), into host cells. CD81 also plays a role in the immune response by regulating the activation and proliferation of T cells and B cells.
Due to its involvement in various diseases, CD81 has become a potential drug target. Recombinant CD81 protein has been used in several studies to understand its role in diseases and to develop therapeutic interventions. Here are some potential applications of CD81 recombinant protein:
As mentioned earlier, CD81 plays a crucial role in the entry of viruses, such as HCV and HIV, into host cells. Therefore, targeting CD81 with recombinant proteins or antibodies could potentially prevent viral infections. In fact, a study has shown that a recombinant CD81 protein can block the entry of HCV into liver cells, making it a promising candidate for anti-HCV therapy.
CD81 is overexpressed in several types of cancer, including breast cancer, colon cancer, and pancreatic cancer. It has been suggested that CD81 promotes the proliferation and migration of cancer cells, making it a potential target for cancer therapy. Recombinant CD81 protein has been used in preclinical studies to inhibit the growth and metastasis of cancer cells, showing promising results.
TEMs, formed by CD81 and other tetraspanins, have been shown to play a role in the uptake and transport of drugs across the cell membrane. Therefore, recombinant CD81 protein can be used as a drug delivery system by conjugating it with therapeutic molecules. This approach has been used in a study to deliver anti-cancer drugs to breast cancer cells, resulting in enhanced drug efficacy.
In conclusion, CD81 is a cell surface protein with a diverse range of functions, including cell signaling, adhesion, and membrane fusion. Its involvement in various diseases, such as viral infections and cancer, makes it a promising drug target.
Reviews
There are no reviews yet.
Your email address will not be published. Required fields are marked *
Your review *
Name *
Email *
Save my name, email, and website in this browser for the next time I comment.
Send us a message from the form below
First name
Last name
Email address
Lab / Company
Phone number
Message
send
Your cart is currently empty.